A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis

NCT03101670 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: filgotinib
DRUG: Placebo Oral Tablet

Sponsor

Lakefront Biotherapeutics NV